Comparison of Direct Oral Anticoagulants Versus Low-Molecular-Weight-Heparins for the Treatment of Cancer Associated Thrombosis

被引:3
|
作者
Phelps, Megan K.
Wiczer, Tracy E.
Erdeljac, H. Paige
Van Deusen, Kelsey R.
Porter, Kyle
Phillips, Gary
Wang, Tzu-Fei
机构
关键词
D O I
10.1182/blood.V128.22.5013.5013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
5013
引用
收藏
页数:6
相关论文
共 50 条
  • [22] Treatment of arterial thrombosis with low molecular weight heparins
    Chesebro, JH
    SEMINARS IN HEMATOLOGY, 1997, 34 (04) : 26 - 34
  • [23] Direct oral anticoagulants versus low-molecular-weight heparins for the treatment of acute venous thromboembolism in patients with gastrointestinal cancer: a systematic review and meta-analysis
    Rungjirajittranon, Tarinee
    Owattanapanich, Weerapat
    Chinthammitr, Yingyong
    Ruchutrakool, Theera
    Suwanawiboon, Bundarika
    THROMBOSIS JOURNAL, 2022, 20 (01)
  • [24] Direct oral anticoagulants versus low-molecular-weight heparins for the treatment of acute venous thromboembolism in patients with gastrointestinal cancer: a systematic review and meta-analysis
    Tarinee Rungjirajittranon
    Weerapat Owattanapanich
    Yingyong Chinthammitr
    Theera Ruchutrakool
    Bundarika Suwanawiboon
    Thrombosis Journal, 20
  • [25] The Role of Direct Oral Anticoagulants in Treatment of Cancer-Associated Thrombosis
    Al-Samkari, Hanny
    Connors, Jean M.
    CANCERS, 2018, 10 (08):
  • [28] Low Molecular Weight Heparin Vs Direct Oral Anticoagulants (Apixaban, Edoxaban and Rivaroxaban) for the Treatment of Cancer Associated Thrombosis: A Cost- Effective Analysis
    Gulati, Shuchi
    Elsisi, Zizi
    Deoghare, Smruti
    Eckman, Mark
    BLOOD, 2019, 134
  • [29] Direct oral anticoagulants or low-molecular-weight heparins for venous thromboembolism in patients with brain tumors
    Lee, Angela
    Oley, Frank, Jr.
    Lo, Mimi
    Fong, Richard
    McGann, Mary
    Saunders, Ila
    Block, Shanna
    Mahajan, Anjlee
    Pon, Tiffany K.
    THROMBOSIS RESEARCH, 2021, 208 : 148 - 155